Back
Live Nation Entertainment, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Buy
58
LYV
Live Nation Entertainment, Inc.
Last Price:
$142.65
Seasonality Move:
6.57%
Sell
26
ORKA
Oruka Therapeutics, Inc.
Last Price:
$30.39
Seasonality Move:
-9.32%
Buy
58
Live Nation Entertainment, Inc. (LYV)
is a Buy
Is Live Nation Entertainment, Inc. a Buy, Sell or Hold?
-
The current Live Nation Entertainment, Inc. [LYV] share price is $142.50. The Score for LYV is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
LYV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $30.31. The Score for ORKA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LYV Stock Price Chart
What is Live Nation Entertainment, Inc.'s stock price today?
-
The Live Nation Entertainment, Inc. share price today is $142.50The current trend is moderately bullish and LYV is experiencing selling pressure, which indicates risk of future bearish movement.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $30.31The current trend is moderately bullish and ORKA is experiencing slight buying pressure.
LYV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 53.45 | Buy |
| Chaikin Money Flow: | -1227982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (133.88 - 143.88) | Buy |
| Bollinger Bands (100): | (138.62 - 164.06) | Sell |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 51.81 | Buy |
| Chaikin Money Flow: | 234570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29 - 31.58) | Buy |
| Bollinger Bands (100): | (16.97 - 29.87) | Buy |
LYV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 143.65 | Sell |
| 20-day SMA: | 141.01 | Buy |
| 50-day SMA: | 140.67 | Buy |
| 200-day SMA: | 145.5 | Sell |
| 8-day EMA: | 143.13 | Sell |
| 20-day EMA: | 141.19 | Buy |
| 50-day EMA: | 142.47 | Buy |
| 200-day EMA: | 143.23 | Sell |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.21 | Sell |
| 20-day SMA: | 30.53 | Sell |
| 50-day SMA: | 28.99 | Buy |
| 200-day SMA: | 17.48 | Buy |
| 8-day EMA: | 30.57 | Sell |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.26 | Buy |
| 200-day EMA: | 21.62 | Buy |
Live Nation Entertainment, Inc. Earnings Growth & LYV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and an increase next year of $1.05 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and a decrease next year of $0.42 per share.
Live Nation Entertainment, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||